BRIEF-Pacira Pharmaceuticals to pay termination fee of about $7.3 mln to CrossLink

* In connection with termination of agreement, fee based on percentage of earned performance-based fees will be due to CrossLink
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.